The Grosinger Family Fund was initiated by the family secondary to their passion for supporting hematological malignancy research initiatives at Karmanos. By embracing Karmanos’s research initiatives in blood cancers it is driving the accelerator forward in the development of innovative technologies and cancer therapies.
The Grosinger family embraces philanthropic funding supporting Karmanos as an NCI-Designated Comprehensive Cancer Center as a leader in transformative cancer care, research and education through compassion, commitment, and perseverance.